SDS

Section 11. Toxicological information
Not available.
Inhalation
:
No known significant effects or critical hazards.
No known significant effects or critical hazards.
:
Ingestion
Skin contact
:
No known significant effects or critical hazards.
May cause damage to organs through prolonged or repeated exposure.
General
:
No known significant effects or critical hazards.
Carcinogenicity
:
No known significant effects or critical hazards.
Mutagenicity
:
May damage the unborn child.
Teratogenicity
:
Developmental effects
:
No known significant effects or critical hazards.
Fertility effects
:
No known significant effects or critical hazards.
Symptoms related to the physical, chemical and toxicological characteristics
Skin contact
Ingestion
Inhalation
Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
Adverse symptoms may include the following:
reduced fetal weight
increase in fetal deaths
skeletal malformations
:
:
:
Eye contact
:
No specific data.
Potential chronic health effects
Delayed and immediate effects and also chronic effects from short and long term exposure
Numerical measures of toxicity
Oral
20150.87 mg/kg
Dermal
105030.76 mg/kg
Route
ATE value
Acute toxicity estimates
Potential immediate
effects
:
Not available.
Short term exposure
Potential delayed effects
:
Not available.
Potential immediate
effects
:
Not available.
Long term exposure
Potential delayed effects
:
Not available.
Date of issue/Date of revision
:
3/3/2020
Date of previous issue
:
2/6/2020
Version
:
3
9/13
21111/61111
MINWAX® POLYCRYLIC® Ultra Flat
SHW-85-NA-GHS-US